Pi Industries Limited · NSE:PIIND
Pi Industries — Q1 FY2024 Earnings Presentation
20 slides from Pi Industries's earnings presentation, May 2025
Slide 1: PI Industries Ltd. Investor Presentation Q1 FY24 Results
PI Industries Ltd. Investor Presentation Q1 FY24 Results 1
Slide 2: Agenda
AGENDA CDR India • Consolidated Financial Performance Siddharth Rangnekar siddharth@cdr-india.com • CSM Exports Nishid Solanki nishid@cdr-india.com • Domestic Agri Brands Tel: +91 22 6645 1221 /1209 Fax: +91 22 6645 1213 • Pharma Updates PI Industries Limited • Business Model and Strategy Rajnish Sa
Slide 3: Solid start to the new fiscal…
Solid start to the new fiscal… Growth momentum continues Revenue EBITDA PAT Figures in Rs. Million *Q1FY24 19,104 24% 4,726 35% 3,829 46% Commercialised one new product Cash flow from PI Health Sciences CSM Exports Trade working capital in Exports and operating activities revenue started Order Book
Slide 4: Demand traction in CSM exports driving growth in Q1FY24
Demand traction in CSM exports driving growth in Q1FY24 CONSOLIDATED Overall 24% Y-o-Y revenue growth (21% excluding Pharma 1) Fig in Rs. Million Q1FY23 Q1FY24 % YOY Revenue 15,432 19,104 24% 33% growth in Exports, excluding Pharma1, driven by volume growth of ~29% and ~4% from price, currency a
Slide 5: The balance sheet continues to remain strong amid focused efforts to improve capital efficiency
The balance sheet continues to remain strong amid focused efforts to improve capital efficiency CONSOLIDATED Fig in Rs. Million Jun-23 Mar-23 Jun-22 Highlights of Q1FY24 Shareholders Fund 76,094 71,985 63,497 Non Current Liabilities 3,891 994 2,837 Total capex for Q1FY24 is Rs. 6,490 million inclu
Slide 6: PI Health Sciences embarked on a long-term value-creation journey..
PI Health Sciences embarked on a long-term value-creation journey.. committed to building a differentiated pharma play • PI Health Sciences Ltd. (PIHS) acquired Archimica S.p.A., Italy on 27th April 2023. Fig in Rs. Million Q1FY24 Ind AS Q1FY24 • PIHS also completed the acquisition of Therachem Rese
Slide 7: State-of-art Manufacturing Assets with a continued thrust to improve sustainability quotient..
State-of-art Manufacturing Assets with a continued thrust to improve sustainability quotient.. Key Material Issues SDG Alignment Key Highlights from FY23 Economic – Contribution to ICT 15 fully automated Multipurpose Plants (MPPs) with Distributed Control system (DCS) innovation spread across 5 loca
Slide 8: Focus on operational excellence to unlock value and efficiencies.
Focus on operational excellence to unlock value and efficiencies. Capacity enhancement carried out for key molecules 16 products achieved Productivity Monthly asset planning forums for RM supply planning Highest M-o-M production Identification and resolution of recurring Production breakdowns
Slide 9: Sustainability at the Core of our Operational Excellence efforts
Sustainability at the Core of our Operational Excellence efforts RCA and CAPA enabled addressal of out of trend in process Zero off-specs in 17 regular Quality Close monitoring of potential failure modes and 6 new products Holistic knowledge transfer during inter-site product transfer 12.9 Kw/
Slide 10: The momentum of new product launches in the domestic market continues.
The momentum of new product launches in the domestic market continues. INSECTICIDE 1 Product launched in Q1FY24 FUNGICIDE DINOACE SECTIN Combination Dual action insecticide for Fungicide with Post Emergence Broad spectrum Rice excellent curative Cotton control against Herbicide Downy mildew & la
Slide 11: The outlook remains positive…
The outlook remains positive… Domestic: • July turnaround in rainfall has enabled a smart pick-up in kharif plantation. Focus on portfolio • Focus on launch of new product launches and growth of the products launched over the last few years diversification with launch of • “Dual growth engine” with
Slide 12: Expecting to sustain the growth momentum backed by multiple growth engines & aggressive M&A
Expecting to sustain the growth momentum backed by multiple growth engines & aggressive M&A Market • Expansion Build Explore and exploit • Creation Customer Intimacy untapped chemistry • Segments Product & Customer-centric services areas • Operation excellence approach Deepening our technological ca
Slide 13: PI's focus on ESG principles is winning accolades.. ranked among the best ESG rated companies globally
PI’s focus on ESG principles is winning accolades.. ranked among the best ESG rated companies globally Environmental Social and Governance SDG Alignment Key Highlights from FY23 Key Material Issues Environment – Climate change 17% reduction in intensity from carbon • 90% of raw material/ packing mat
Slide 14: People first: HR Snapshots
People first: HR Snapshots 89% employees PI compass training provided to define Culture covered culture through clear observable actions 86 employees Training from IIT Madras & NITIE Mumbai Capability - in WPS,PS & Quality. Development covered Talent 27 GET & 117 Building a talent pool pipelin
Slide 15: Our CSR efforts focused on community welfare & environment
Our CSR efforts focused on community welfare & environment CSR policy directed towards inclusive development that creates value for the society, especially around our plant and farmers across the country Project Vriddhi Employability-linked Project Asmita Improve Health and Nutrition Skill Developme
Slide 16: Rewards and Recognition
Rewards and Recognition Chairman at CII-NR MR. MAYANK SINGHAL Golden Peacock National CSR Award 2022 chosen as the Chairman at A testament to PI’s successful purpose-driven CII-NR Regional Committee and innovative CSR interventions on Agriculture Food Processing & Dairy for FY23 Golden Peacock Quali
Slide 17: Performance underpinned by PI's Compass
Performance underpinned by PI’s Compass Purpose Reimagining a healthier planet Vision Lead with science, technology and human ingenuity to create transformative solutions in life sciences Capabilities Partner centric First to identify and deliver on latent needs of our customers and partners Science
Slide 18: Presence across the Agchem value chain
Presence across the Agchem value chain Strong focus on customer needs and continuous innovation Domestic Agri CSM Exports Brands Regulatory services Marketing & Discovery Development Scale-up Manufacturing Evaluation & Trials & Registrations Distribution Customer Needs Business Strategy Consistent Q
Slide 19: Business model built on the principles of respect for IP and established relationships
Business model built on the principles of respect for IP and established relationships Leading Agchem Distribution India’s largest CRAMS Company Company in India with Domestic Brand Market with majority revenue from Exports Market leading market share in Patented Products certain crops Leveraging ou
Slide 20: Thank You
Inspired by Science